phrma logo

PhRMA

PhRMA Sites

Login

Explore Member-Only Resources

Access exclusive advocacy, policy, and research materials through the member site.

Login now

About

About

Our Agenda

Our Agenda

Policy Issues

We believe that patients should have access to innovative medicines.

Learn More

Innovation Ecosystem

Intellectual Property

Research & Development

Future of Medicine

Government Price Setting

International

Innovation Ecosystem

Patient Access & Affordability

PBMs & Middlemen

Hospitals and 340B

Insurance Coverage

Cost of Medicines

Medicare & Medicaid

Patient Access & Affordability

Resources

Our mission is to conduct effective advocacy for public policies that encourage the discovery of important, new medicines for patients by biopharmaceutical research companies.

Learn More

Resources

Resources

Newsroom

Newsroom

Blog

Blog

America's Medicines

PhRMA Foundation

PhRMA Foundation Logo

Voters for Cures

VotersForCures.org Logo

Working for Cures

workersforcures.org logo

This is Innovation

Innovation.org logo

View More

Search in PhRMA

Find resources, news, and articles related to policy issues and scientific innovation.

What are you looking for?

Most Recent

Policy Paper

Press

Blog

Report

Fact Sheet

Event

Resource

Pages

Leader

Author

Comment

/resources

About PhRMA

The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are laser focused on developing innovative medicines that transform lives and create a healthier world. Together, we are fighting for solutions to ensure patients can access and afford medicines that prevent, treat and cure disease. Over the last decade, PhRMA member companies have invested more than $850 billion in the search for new treatments and cures, and they support nearly five million jobs in the United States.

Connect with PhRMA

For information on how innovative medicines save lives, please visit:  
www.PhRMA.org
www.VotersforCures.org
www.AmericasMedicines.com
www.Facebook.com/PhRMA 
www.X.com/PhRMA 

WASHINGTON, D.C. (November 17, 2026) – Pharmaceutical Research and Manufacturers of America (PhRMA) Chief Medical Officer Dr. Michael Ybarra issued the following statement on the United States losing its measles elimination status: 
 
“America’s loss of measles elimination status is a sobering and entirely preventable public health failure that has already cost lives and now puts more at risk. Measles is one of the most contagious viruses in the world — it can hospitalize children and adults, cause pneumonia, brain swelling and as we have been reminded, can be deadly. Tragically, at least ten measles-associated deaths have been reported to state health departments this year.
 
“The United States has held measles elimination status since 2000 because safe, highly effective vaccines stopped the virus from circulating continuously in our communities. Developed by U.S. scientists and studied for decades, the measles vaccine remains essential to protecting public health. Two doses of the MMR vaccine are 97% effective at preventing measles. But measles elimination requires high population uptake. When vaccination rates are high, the virus can’t spread, but when vaccination rates fall, outbreaks can return and put vulnerable Americans at risk.  
 
“Losing measles elimination status signals that a dangerous, preventable disease is once again spreading in American communities. Continued outbreaks put families at risk, disrupt schools and workplaces and strain our health care system, while also undermining America's longstanding leadership in preventing infectious diseases. 
 
“We urge policymakers to provide clear, accurate information about the seriousness of measles infection and the effectiveness of vaccines against it, restore and sustain high vaccination coverage in every community, strengthen vaccination efforts, and invest in disease surveillance and rapid outbreak response. We have the tools to eliminate measles again and what we need now is the commitment to use them.”

Press Release

PhRMA Statement on America Losing Measles Elimination Status

November 17, 2026

Stay current on policy making

Sign up for email updates and follow us on social. 

About

Our Agenda

Policy Issues

Resources

Blog

Contact Us

Privacy Policy

Terms of Service

Facebook

Facebook

X

Twitter X

LinkedIn

LinkedIn

Instagram

instagram logo

America's Medicines

PhRMA Foundation

Voters for Cures

Working for Cures

Innovation.org

Please type your email

Success!

You've been added to the list